The contemporary pharmaceutical supply chain operates at a complex nexus where public healthcare affordability, life sciences intellectual property protections, and intense multi-tier distribution networks intersect across global health landscapes. Within this highly integrated architecture, the optimization of medication cost structures, the reduction of public healthcare expenditures, and the expansion of consumer access rely almost entirely […]